🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseAlcohol + MASH + GLP-1 — need advice Page 3

Alcohol + MASH + GLP-1 — need advice

sarah_nash92 Wed, Jun 26, 2024 at 11:40 AM 12 replies 1,927 viewsPage 3 of 3
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Jun 28, 2024 at 4:04 AM#11
james_edin said:
The liver data is among the strongest non-weight findings in the class.

Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.

9 7BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 6 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jun 28, 2024 at 6:17 AM#12

Clinical perspective, offered as context rather than as advice. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

10 8NauseaFreeNow, SteveThurs, B12Beth and 7 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jun 28, 2024 at 8:30 AM#13
Dr.PulmRoch said:
The useful move here is to separate what is established from what is widely repeated.

This is where I part company with the consensus forming above. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

11 9jennifer_SEA, tyler_CSCS, VanRx_Mike and 8 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Jun 28, 2024 at 10:43 AM#14

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

12 10Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 9 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 28, 2024 at 12:56 PM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out. Carry on.

13 11PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 10 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register